Previous studies have demonstrated that STING deficiency prevents cell death, inflammation, and fibrosis in various liver disease models, such as acute or chronic CCl4 injection1, diet-induced nonalcoholic fatty liver disease (NAFLD)2, and early alcoholic liver disease (ALD)36. Here, STING1 is linked to alcoholic liver diseases.